Morgan Stanley Surmodics Inc Transaction History

Morgan Stanley

$1.36 Trillion
Q1 2025

A detailed history of Morgan Stanley transactions in Surmodics Inc stock. As of the latest transaction made, Morgan Stanley holds 675,989 shares of SRDX stock, worth $20.2 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

675,989

Previous 674,641 0.2%

Holding current value

$20.2 Million

Previous $26.7 Million 22.75%

% of portfolio

0.0%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	BUY	$26.71 - $39.71 $36,005 - $53,529	1,348 Added 0.2%	675,989 $20.6 Million
Q4 2024 Feb 14, 2025	SELL	$37.5 - $40.13 $2.93 Million - $3.13 Million	-78,065 Reduced 10.37%	674,641 $26.7 Million
Q3 2024 May 14, 2025	SELL	$38.47 - $42.24 $14 Million - $15.3 Million	-363,371 Reduced 32.56%	752,706 $29.2 Million
Q3 2024 Nov 14, 2024	SELL	$38.47 - $42.24 $14 Million - $15.3 Million	-363,371 Reduced 32.56%	752,706 $29.2 Million
Q2 2024 May 14, 2025	BUY	$25.39 - $42.1 $11.2 Million - $18.6 Million	441,436 Added 65.43%	1,116,077 $46.9 Million
Q2 2024 Oct 17, 2024	BUY	$25.39 - $42.1 $6.66 Million - $11 Million	262,162 Added 30.7%	1,116,077 $46.9 Million
Q2 2024 Aug 14, 2024	BUY	$25.39 - $42.1 $6.66 Million - $11 Million	262,162 Added 30.7%	1,116,077 $46.9 Million
Q1 2024 Oct 17, 2024	SELL	$27.44 - $35.56 $7.19 Million - $9.32 Million	-262,162 Reduced 23.49%	853,915 $25.1 Million
Q1 2024 Aug 16, 2024	SELL	$27.44 - $35.56 $10.6 Million - $13.8 Million	-387,878 Reduced 31.24%	853,915 $25.1 Million
Q1 2024 May 15, 2024	SELL	$27.44 - $35.56 $10.6 Million - $13.8 Million	-387,878 Reduced 31.24%	853,915 $25.1 Million
Q4 2023 Aug 16, 2024	BUY	$28.47 - $38.49 $3.58 Million - $4.84 Million	125,716 Added 11.26%	1,241,793 $45.1 Million
Q4 2023 Feb 13, 2024	BUY	$28.47 - $38.49 $31.9 Million - $43.1 Million	1,118,919 Added 910.62%	1,241,793 $45.1 Million
Q3 2023 Nov 15, 2023	BUY	$28.28 - $38.36 $1.76 Million - $2.39 Million	62,310 Added 102.88%	122,874 $3.94 Million
Q2 2023 Aug 14, 2023	SELL	$17.67 - $31.31 $79,020 - $140,018	-4,472 Reduced 6.88%	60,564 $1.9 Million
Q1 2023 May 15, 2023	SELL	$17.13 - $38.52 $337,854 - $759,729	-19,723 Reduced 23.27%	65,036 $1.48 Million
Q4 2022 Feb 14, 2023	SELL	$29.44 - $37.31 $30,588 - $38,765	-1,039 Reduced 1.21%	84,759 $2.89 Million
Q3 2022 Nov 14, 2022	SELL	$28.84 - $38.92 $739,659 - $998,181	-25,647 Reduced 23.01%	85,798 $2.61 Million
Q2 2022 Oct 27, 2022	BUY	$33.25 - $45.11 $1.95 Million - $2.64 Million	58,556 Added 110.71%	111,445 $4.15 Million
Q2 2022 Aug 15, 2022	BUY	$33.25 - $45.11 $1.95 Million - $2.64 Million	58,556 Added 110.71%	111,445 $4.15 Million
Q1 2022 Oct 27, 2022	SELL	$40.68 - $49.72 $2.38 Million - $2.91 Million	-58,556 Reduced 52.54%	52,889 $2.4 Million
Q1 2022 May 13, 2022	SELL	$40.68 - $49.72 $49,182 - $60,111	-1,209 Reduced 2.23%	52,889 $2.4 Million
Q4 2021 Feb 14, 2022	BUY	$43.21 - $57.6 $120,858 - $161,107	2,797 Added 5.45%	54,098 $2.6 Million
Q3 2021 Nov 15, 2021	BUY	$52.8 - $60.32 $2.71 Million - $3.09 Million	51,301 New	51,301 $2.85 Million

Others Institutions Holding SRDX

# of Institutions

140

Shares Held

12.1M

Call Options Held

31.3K

Put Options Held

17.9K

View Full List

About SURMODICS INC

Ticker SRDX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 14,005,000
Market Cap $418M
Description
Surmodics, Inc., together with its subsidiaries, provides surface modification technologies for intravascular medical devices, and chemical components for in vitro diagnostic immunoassay tests and microarrays in the United States and internationally. It operates in two segments, Medical Device and In Vitro Diagnostics (IVD). The Medical Device s...

More about SRDX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.

Account